Global Small Animal Imaging (In-Vivo) Market, By Modality (Optical Imaging Systems, Nuclear Imaging, Micro-Magnetic Resonance Imaging (MRI), Micro-Ultrasound, Micro-CT, Magnetic Particle Imaging (MPI) Systems, Photoacoustic Imaging Systems), Application (Monitoring Drug Treatment Response, Bio Distribution Studies, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Epigenetics), Reagents (Optical Imaging Reagents, MRI Contrast Agents, Ultrasound Contrast Agents, Nuclear Imaging reagents, CT contrast Agents), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights : Global Small Animal Imaging (In-Vivo) Market
The small animal imaging (in-vivo) market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to grow at a CAGR of 8.55% in the above-mentioned forecast period. Increasing use of imaging technological advancements in molecular imaging drives the small animal imaging (in-vivo) market.
In vivo imaging of small animals (mice) is rising day by day for the development of drugs mainly in the therapeutic area of oncology/cancer. Its main application is monitoring treatment response for the indications. Imaging systems which are mostly used for detection are MRI, optical imaging system and positron emission tomography (PET).
Rise in the rapid demand for non-invasive small animal imaging techniques is the vital factor escalating the market growth, also rise in the growth in research funding for various development done by private as well as public organizations, rise in the growth of pharmaceutical companies and research organizations and rise in the rapid development in many areas such as chemistry, computer, engineering, medicine and molecular biology are the major factors among others driving the small animal imaging (in-vivo) market. Moreover, rise in the demand from emerging economies and rise in the research and development activities in the market will further create new opportunities for small animal imaging (in-vivo) market in the forecasted period of 2021-2028.
However, rise in the strict regulations governing small animal research, increase in the inadequate number of skilled researchers and the bitter condition of the infrastructure and rise in the rigid healthcare expenditures in various countries are the major factors among others which will obstruct the market growth, and will further challenge the growth of small animal imaging (in-vivo) market in the forecast period mentioned above.
The small animal imaging (in-vivo) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the small animal imaging (in-vivo) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Small Animal Imaging (in-vivo) Market Scope and Market Size
The small animal imaging (in-vivo) market is segmented on the basis of modality, application and reagents. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of modality, the small animal imaging (in-vivo) market is segmented into optical imaging systems, nuclear imaging, micro-magnetic resonance imaging (MRI), micro-ultrasound, micro-CT, magnetic particle imaging (MPI) systems and photoacoustic imaging systems.
- Based on application, the small animal imaging (in-vivo) market is segmented into monitoring drug treatment response, bio distribution studies, cancer cell detection, biomarkers, longitudinal studies and epigenetics.
- The small animal imaging (in-vivo) market is also segmented on the basis of reagents into optical imaging reagents, MRI contrast agents, ultrasound contrast agents, nuclear imaging reagents and CT contrast agents.
Small Animal Imaging (in-vivo) Market Country Level Analysis
The small animal imaging (in-vivo) market is analysed and market size insights and trends are provided by country, modality, application and reagents as referenced above.
The countries covered in the small animal imaging (in-vivo) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the small animal imaging (in-vivo) market due to rise in the growth in research funding for various development done by private as well as public organizations and rise in the growth of pharmaceutical companies and research organizations in this region. Europe is the expected region in terms of growth in small animal imaging (in-vivo) market due to rise in the presence of a large number of diagnostic device manufacturers, clinical research, and pharmaceutical organizations in this region.
The country section of the small animal imaging (in-vivo) market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The small animal imaging (in-vivo) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for small animal imaging (in-vivo) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the small animal imaging (in-vivo) market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Small Animal Imaging (in-vivo) Market Share Analysis
The small animal imaging (in-vivo) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to small animal imaging (in-vivo) market.
The major players covered in the small animal imaging (in-vivo) market report are Aspect Imaging, Bruker, FUJIFILM Holdings Corporation, LI-COR, Inc, Life Technologies, Mediso Ltd, MiLabs B.V., Miltenyi Biotech GmbH, PerkinElmer, Inc., Promega Corporation, Siemens AG, Genovis Ab, Thermo Fisher Scientific, Life Technologies Corporation, Targeson, Inc., Agilent Technologies, Inc., Scanco Medical Ag, MR Solutions Ltd., Bioscan, Inc., Spectral Instruments Imaging, Sofie Biosciences, Inc and Trifoil Imaging among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-